High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program (Q33382175)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program
scientific article

    Statements

    High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program (English)
    Joseph R Mikhael
    Andrew R Belch
    H Miles Prince
    Maria Nambo Lucio
    Angelo Maiolino
    Alessandro Corso
    Maria Teresa Petrucci
    A Keith Stewart
    19 November 2008

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit